WeLeader Biomedical Co. Ltd.(TW:7713)
NT$70.600.00 (0.00%)
TW:7713
WeLeader Biomedical Co. Ltd. financials statements
NT$70.60
At close:0.00 (0.00%)
WeLeader Biomedical Co. Ltd. (7713) Income Statement
WeLeader Biomedical Co. Ltd. Income Statement
Last quarter (Q2 2026), WeLeader Biomedical Co. Ltd.'s total revenue was NT$339.12M, an increase of 24.18% from the same quarter last year. In Q2, WeLeader Biomedical Co. Ltd.'s net income was NT$78.67M. See WeLeader Biomedical Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Jun 23 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.11B | NT$ 991.13M | NT$ 940.70M | NT$ 1.04B | NT$ 841.14M | |
| NT$ 370.97M | NT$ 316.32M | NT$ 298.08M | NT$ 291.75M | NT$ 218.92M | |
| NT$ 109.74M | NT$ 102.13M | NT$ 100.59M | NT$ 97.64M | NT$ 86.65M | |
| Depreciation and Amortization | NT$ 123.03M | NT$ 108.58M | NT$ 103.80M | NT$ 109.82M | NT$ 114.44M |
| NT$ 384.25M | NT$ 329.59M | NT$ 303.04M | NT$ 306.57M | NT$ 252.06M | |
| NT$ 261.22M | NT$ 214.20M | NT$ 197.49M | NT$ 194.11M | NT$ 132.28M | |
| NT$ -239.00K | NT$ 1.07M | NT$ -3.94M | NT$ -1.56M | NT$ -818.00K | |
| NT$ 260.98M | NT$ 215.21M | NT$ 193.54M | NT$ 192.54M | NT$ 131.46M | |
| NT$ 208.56M | NT$ 170.21M | NT$ 152.28M | NT$ 153.80M | NT$ 105.77M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 4.64 | NT$ 4.09 | NT$ 3.74 | NT$ 4.40 | NT$ 3.79 |
| Diluted EPS | NT$ 4.64 | NT$ 4.09 | NT$ 3.71 | NT$ 4.34 | NT$ 3.76 |
| Weighted Average Shares Outstanding | 44.95M | 41.57M | 40.72M | 34.95M | 27.88M |
| Weighted Average Shares Outstanding (Diluted) | 44.95M | 41.57M | 41.58M | 35.44M | 28.10M |
Currency in TWD
